×
  • Category
  • Type
  • Advanced

Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap

Q&A for Session #14: Monitoring and Evaluating COVID-19 Vaccine Introduction

Q&A for Session #13: Private Sector Engagement

COVID-19 Vaccine Explainer - COVID-19 Vaccine (Vero Cell), Inactivated (Sinopharm)

Alteration in vaccination rates and an evaluation of physicians' perceptions of the possible impact of the SARS-CoV-2 pandemic on childhood vaccinations in Ankara, Turkey

COVID-19 disrupts vaccine delivery

Findings from a healthcare worker evaluation of the COVID19 vaccine label

COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)

COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence

The role of health workers in COVID-19 vaccination - implementation support guide

Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm

Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm

COVID-19 Vaccine Communication Resources

Q&A for Session #12: Microplanning and Supportive Supervision

Impact de la pandémie COVID-19 sur la vaccination des enfants au Maroc: enquête électronique auprès de 103 pédiatres

Latin American forum on immunization services during the COVID-19 pandemic

Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis

Inequalities in COVID-19 disruption of routine immunisations and returning to pre-COVID immunisation rates

Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions